The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Randomized Comparison of a High Clopidogrel Maintenance Dose in Patients With Diabetes Mellitus and Coronary Artery Disease: Results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) Study
Open accessAbstract
Background— After treatment with clopidogrel, patients with type 2 diabetes mellitus (T2DM) have reduced platelet inhibition compared with patients who are not diabetic. Whether platelet inhibition can be enhanced by increasing clopidogrel maintenance dosage in T2DM patients is unknown. The aim of this pilot study was to assess the functional impact of a high maintenance dose in T2DM patients with suboptimal clopidogrel-induced antiplatelet effects. Methods and Results— T2DM patients on chronic dual antiplatelet therapy were screened to identify suboptimal clopidogrel responders. The latter were randomized to 30-day treatment with a standard (75 mg; n=20) or high (150 mg; n=20) daily maintenance dose. Platelet function was assessed at 3 time points: baseline, 30 days after randomization, and 30 days after resuming standard dosing. Platelet function parameters included adenosine diphosphate–induced (20 and 5 μmol/L) maximal and late platelet aggregation, inhibition of platelet aggregation, platelet disaggregation, and P2Y 12 reactivity index. A total of 64 T2DM patients were screened to identify 40 suboptimal responders. After randomization, maximal adenosine diphosphate–induced (20 μmol/L) platelet aggregation was significantly reduced in the 150-mg group compared with the 75-mg group ( P =0.002; primary end point). However, suboptimal clopidogrel response was still present in 60% of patients on the 150-mg regimen. All other platelet function parameters showed enhanced clopidogrel-induced antiplatelet effects with 150 mg, which returned to baseline values after resumption of standard dosing. Conclusions— A 150-mg maintenance dose of clopidogrel is associated with enhanced antiplatelet effects compared with 75 mg in high-risk T2DM patients. However, enhanced ex vivo platelet reactivity continues to persist, the clinical implications of which are unknown and need to be evaluated in large-scale clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
(2001) · New England Journal of Medicine · doi:10.1056/nejmoa010746 · Cited by 6,470
Iakovou, I. (2005) · JAMA · doi:10.1001/jama.293.17.2126 · Cited by 3,132
Steinhubl, S. R., Berger, P. B., Mann III, J. T., Fry, E. T. A., DeLago, A., Wilmer, C., Topol, E. J., & for the CREDO Investigators (2002) · JAMA · doi:10.1001/jama.288.19.2411 · Cited by 3,078
Tödtling, F., & Trippl, M. (2005) · Research Policy · doi:10.1016/j.respol.2005.01.018 · Cited by 2,571
WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
Gurbel, P. A., Bliden, K. P., Hiatt, B. L., & O’Connor, C. M. (2003) · Circulation · doi:10.1161/01.cir.0000072771.11429.83 · Cited by 1,544
Matetzky, S., Shenkman, B., Guetta, V., Shechter, M., Beinart, R., Goldenberg, I., Novikov, I., Pres, H., Savion, N., Varon, D., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130846.46168.03 · Cited by 1,354
Variability in Individual Responsiveness to Clopidogrel
Angiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Alfonso, F., Macaya, C., Bass, T. A., & Costa, M. A. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.044 · Cited by 959
Self-citationPeters, R. J. G., Mehta, S. R., Fox, K. A. A., Zhao, F., Lewis, B. S., Kopecky, S. L., Diaz, R., Commerford, P. J., Valentin, V., & Yusuf, S. (2003) · Circulation · doi:10.1161/01.cir.0000091201.39590.cb · Cited by 706
Patti, G., Colonna, G., Pasceri, V., Pepe, L. L., Montinaro, A., & Di Sciascio, G. (2005) · Circulation · doi:10.1161/01.cir.0000161383.06692.d4 · Cited by 652
Platelet Reactivity in Patients and Recurrent Events Post-Stenting
Gurbel, P. A., Bliden, K. P., Guyer, K., Cho, P. W., Zaman, K. A., Kreutz, R. P., Bassi, A. K., & Tantry, U. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.041 · Cited by 644
Hochholzer, W., Trenk, D., Bestehorn, H.-P., Fischer, B., Valina, C. M., Ferenc, M., Gick, M., Caputo, A., Büttner, H. J., & Neumann, F.-J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.065 · Cited by 589
Angiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Ramírez, C., Sabaté, M., Jimenez-Quevedo, P., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2430 · Cited by 538
Self-citationClopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis
Gurbel, P. A., Bliden, K. P., Samara, W., Yoho, J. A., Hayes, K., Fissha, M. Z., & Tantry, U. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.056 · Cited by 536
Platelet activation in type 2 diabetes mellitus
Ferroni, P., Basili, S., Falco, A., & Davì, G. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00836.x · Cited by 493
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus
Bhatt, D. L., Marso, S. P., Hirsch, A. T., Ringleb, P. A., Hacke, W., & Topol, E. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02567-5 · Cited by 409
Gurbel, P. A., Bliden, K. P., Hayes, K. M., Yoho, J. A., Herzog, W. R., & Tantry, U. S. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.030 · Cited by 381
CUISSET, T., FRERE, C., QUILICI, J., BARBOU, F., MORANGE, P. E., HOVASSE, T., BONNET, J., & ALESSI, M. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01751.x · Cited by 369
Cuisset, T., Frere, C., Quilici, J., Morange, P.-E., Nait-Saidi, L., Carvajal, J., Lehmann, A., Lambert, M., Bonnet, J.-L., & Alessi, M.-C. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.06.049 · Cited by 343
Tantry, U. S., Bliden, K. P., & Gurbel, P. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.090 · Cited by 324
Angiolillo, D. J., Bernardo, E., Ramírez, C., Costa, M. A., Sabaté, M., Jimenez-Quevedo, P., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.038 · Cited by 310
Self-citationANGIOLILLO, D. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.036 · Cited by 303
Self-citationAngiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Ramírez, C., Cavallari, U., Trabetti, E., Sabaté, M., Hernández, R., Moreno, R., Escaned, J., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000223867.25324.1a · Cited by 228
Self-citationPlatelet Inhibition by Insulin Is Absent in Type 2 Diabetes Mellitus
Ferreira, I. A., Mocking, A. I. M., Feijge, M. A. H., Gorter, G., van Haeften, T. W., Heemskerk, J. W. M., & Akkerman, J.-W. N. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000199519.37089.a0 · Cited by 213
Kastrati, A., von Beckerath, N., Joost, A., Pogatsa-Murray, G., Gorchakova, O., & Schömig, A. (2004) · Circulation · doi:10.1161/01.cir.0000137972.74120.12 · Cited by 196
Angiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Ramírez, C., Barrera-Ramirez, C., Sabaté, M., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2005) · Thrombosis Research · doi:10.1016/j.thromres.2004.07.007 · Cited by 176
Self-citationThe difference between clopidogrel responsiveness and posttreatment platelet reactivity
Samara, W. M., Bliden, K. P., Tantry, U. S., & Gurbel, P. A. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.07.002 · Cited by 148
Labarthe, B., Théroux, P., Angioı̈, M., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.02.092 · Cited by 126
IRS-1 Mediates Inhibition of Ca2+ Mobilization by Insulin via the Inhibitory G-protein Gi
Ferreira, I. A., Eybrechts, K. L., Mocking, A. I. M., Kroner, C., & Akkerman, J. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305474200 · Cited by 117
Angiolillo, D. J., Fernández‐Ortíz, A., Bernardo, E., Ramírez, C., Sabaté, M., Jiménez‐Quevedo, P., Hernández, R., Moreno, R., Escaned, J., Alfonso, F., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.106 · Cited by 113
Self-citationPlatelet Function Assessment to Predict Outcomes After Coronary Interventions
Alfonso, F., & Angiolillo, D. J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.009 · Cited by 46
Self-citationAlberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
Cited by
Price, M. J. (2011) · JAMA · doi:10.1001/jama.2011.290 · Cited by 1,308
Bonello, L., Tantry, U. S., Marcucci, R., Blindt, R., Angiolillo, D. J., Becker, R., Bhatt, D. L., Cattaneo, M., Collet, J. P., Cuisset, T., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.047 · Cited by 1,149
Self-citationCollet, J.-P., Hulot, J.-S., Pena, A., Villard, E., Esteve, J.-B., Silvain, J., Payot, L., Brugier, D., Cayla, G., Beygui, F., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61845-0 · Cited by 967
Variability in Individual Responsiveness to Clopidogrel
Angiolillo, D. J., Fernandez-Ortiz, A., Bernardo, E., Alfonso, F., Macaya, C., Bass, T. A., & Costa, M. A. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.11.044 · Cited by 959
Self-citationWiviott, S. D., Trenk, D., Frelinger, A. L., O’Donoghue, M., Neumann, F.-J., Michelson, A. D., Angiolillo, D. J., Hod, H., Montalescot, G., Miller, D. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.740324 · Cited by 881
Self-citation
Metadata
- Authors
- Angiolillo, D. J., Shoemaker, S. B., Desai, B., Yuan, H., Charlton, R. K., Bernardo, E., Zenni, M. M., Guzman, L. A., Bass, T. A., & Costa, M. A.
- Venue
- Circulation
- Published
- 2007-02-13
- Volume
- 115
- Issue
- 6
- Pages
- 708-716
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2048708470
- Cited by
- 447
- References
- 33
- FWCI
- 45.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.